NATIONAL NEWS

The White House is threatening the patents of high-priced drugs developed with taxpayer dollars

Dec 7, 2023, 6:16 AM

FILE - President Joe Biden speaks during an event on prescription drug costs, in the East Room of t...

FILE - President Joe Biden speaks during an event on prescription drug costs, in the East Room of the White House, Aug. 29, 2023, in Washington. The Biden administration is putting pharmaceutical companies on notice. It's warning them that if the price of certain drugs is too high, they might allow other companies to make their product. Under the new plan, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money. (AP Photo/Evan Vucci, File)
Credit: ASSOCIATED PRESS

(AP Photo/Evan Vucci, File)

WASHINGTON (AP) — The Biden administration is putting pharmaceutical companies on notice, warning them that if the price of certain drugs is too high, the government might cancel their patent protection and allow rivals to make their own versions.

Under a plan announced Thursday, the government would consider overriding the patent for high-priced drugs that have been developed with the help of taxpayer money and letting competitors make them in hopes of driving down the cost.

In a 15-second video released to YouTube on Wednesday night, President Joe Biden promised the move would lower prices.

“Today, we’re taking a very important step toward ending price gouging so you don’t have to pay more for the medicine you need,” he said.

The administration did not immediately release details about how the process will work and how it will deem a drug costly enough to act. White House officials would not name drugs that might potentially be targeted.

There will be a 60-day public comment period. If the plan is enacted, drugmakers are almost certain to challenge it in court.

It’s the latest health policy pitch from a White House gearing up to make its efforts to tackle drug prices a central theme in next year’s reelection campaign. Biden frequently talks about the $35 cap on insulin for Medicare enrollees that went into effect this year, as well as a plan for government officials to negotiate some drug prices paid by Medicare for the first time in history.

The federal government, however, has never taken such a move against patents, a step called “march-in rights.” But some Democratic lawmakers, including Sens. Elizabeth Warren of Massachusetts and Amy Klobuchar of Minnesota, has in recent years lobbied the Health and Human Services agency to do so with certain drugs.

The conditions for how those “march-in rights” would be used have long been debated. Pharmaceutical companies have pushed back on the idea that prices alone are enough for Washington to act against a drug’s patent. The process proposed by the administration would clarify that the drug’s patent could be in jeopardy if its price is out of reach for Americans, White House officials said.

“For the first time, ever, the high price of that taxpayer-funded drug is a factor in determining that the drug is not accessible to the public on reasonable terms,” said Biden domestic policy adviser Neera Tanden.

The plan could threaten future drugs, according to the pharmaceutical lobbying firm Pharmaceutical Research and Manufacturers of America, or PhRMA.

“This would be yet another loss for American patients who rely on public-private sector collaboration to advance new treatments and cures,” PhRMA spokesperson Megan Van Etten said.

Pharmaceutical companies have long relied on government research to develop new drugs. The most recent major breakthrough was the development of COVID-19 vaccines. U.S. taxpayers invested billions of dollars in the effort and were able, until recently, to access treatments and preventions for the virus without paying out-of-pocket for them.

When the public invests heavily in a private company’s drug, it’s fair to question whether they should have to pay high prices for it, said William Pierce, a former HHS official during President George W. Bush’s administration.

“The question becomes – what reward should there be for the taxpayers who help fund this product?” Pierce said.

National News

Associated Press

A New York collector pleads guilty to smuggling rare birdwing butterflies

NEW YORK (AP) — A Long Island man has pleaded guilty to illegally trafficking birdwing butterflies and other rare insects, according to a plea deal filed in Brooklyn federal court Tuesday. Charles Limmer, 75, of Commack, pleaded guilty to a charge of conspiracy to smuggle wildlife into the country and agreed to pay a $30,215 […]

19 minutes ago

Associated Press

A pregnant Amish woman is killed in her rural Pennsylvania home, and police have no suspects

SPARTANSBURG, Pa. (AP) — Investigators have no suspects in the killing of a pregnant 23-year-old Amish woman inside her home in rural northwestern Pennsylvania, and are appealing for tips from the public to help solve the crime, a state police spokeswoman said Wednesday. Rebekah A. Byler was the victim of a criminal homicide inside her […]

41 minutes ago

Associated Press

Police in suburban Chicago are sued over a fatal shooting of a man in his home

CHICAGO (AP) — The sisters of a man fatally shot in his home this month by suburban Chicago police filed a federal lawsuit Wednesday against the officers and their department, alleging wrongful death and other counts. Kyenna McConico and Kennetha Barnes, sisters of Isaac Goodlow III, filed the lawsuit in U.S. District Court in Chicago […]

2 hours ago

Workers drive among shipping containers and trailers at a BNSF intermodal terminal, Jan. 3, 2024, i...

Associated Press

US economy grew solid 3.2% in fourth quarter, a slight downgrade from government’s initial estimate

WASHINGTON (AP) — The U.S. economy grew at a robust 3.2% annual pace from October through December, propelled by healthy consumer spending, the Commerce Department reported Wednesday in a slight downgrade from its initial estimate. The expansion in the nation’s gross domestic product — the economy’s total output of goods and services — slipped from […]

3 hours ago

FILE - Activists mark the first anniversary of the Supreme Court's decision in Dobbs v. Jackson Wom...

Associated Press

About as many abortions are happening in the US monthly as before Roe was overturned, report finds

The number of abortions performed each month is about the same as before the U.S. Supreme Court overturned Roe v. Wade and the nationwide right to abortion more than a year and a half ago, a new report finds. The latest edition of the #WeCount report conducted for the Society of Family Planning, a nonprofit […]

3 hours ago

This undated photo shows oral historian Francine D. Spang-Willis, who is leading a project to creat...

Associated Press

Laurene Powell Jobs’ philanthropy seeks to strengthen communities with grants for local leaders

Francine Spang-Willis wishes the landscape of the Crazy Mountains near Livingston, Montana, could speak for itself. But absent that, the oral historian will launch a new project talking to people with a connection to the land. Spang-Willis is one of a dozen new fellows announced Wednesday by the Emerson Collective, Laurene Powell Jobs’ philanthropy. In […]

3 hours ago

The White House is threatening the patents of high-priced drugs developed with taxpayer dollars